drugset / Trial / NCT01102140
The Impact of Pomegranate Extract on Chronic Cardiomyopathy Complicated by Renal Insufficiency (ImPrOVE): a Pilot Study
RandomizedParallel-groupSingle-blindTreatment
Summary
This blinded, controlled study will examine the impact of pomegranate polyphenol extract (POMx, from Pom Wonderful, LLC), 1000mg on cardiomyopathy in subjects with chronic renal insufficiency.
Timeline
- Start
- 2010-07
- Primary completion
- 2013-05-31
- Completion
- 2013-05-31
Outcome
Outcome not reported
Stopped: “Investigator left University of Michigan”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | pomegranate polyphenol extract | Unknown | 1000 mg | Oral |